Ligand Pharmaceuticals best choise in the Biopharma Industry

NASDAQ:LGND   Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Ligand Pharmaceuticals has a compelling business model that offers higher than average return with lower than average risk.
Ligand's P/E of 8 is cheap as I mentioned. Forward P/E is indeed higher compared to the industry but I think it is still in range. Even if it is expensive, I think it is justified given the high return to equity that Ligand has generated in 2015. And as a growth stock, Ligand's growth comes at a cheaper price compared to the industry as represented by PE/G. So, do I think Ligand's a buy at this level? I think so

Price broke important level of resistance at $112 and had a nice run to $132. No we are in pullback, restesting previous resistance that now can act like support. And looks like we are curling up and can see new highs soon

Trade and Risk management:
We already have an initial entry, as price came out of consolidation above $121. 40 . I will initiate small position here with stop below $114.50 and will see if it can build new construction in front of high at $131.85 ot add to my position.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.